Evaluating Acalabrutinib In The Treatment Of Mantle Cell Lymphoma: Design, Development, And Place In Therapy

Mantle cell lymphoma (MCL) is an incurable intermediate-grade lymphoma representing 5–6% of non-Hodgkin’s lymphomas diagnosed in the United States. The introduction of inhibitors of Bruton’s tyrosine kinase (BTK) into targeted therapy for MCL has significantly improved outcomes in patients with rela...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Onco Targets Ther
Main Authors: Girard, Jennifer, Reneau, John, Devata, Sumana, Wilcox, Ryan A, Kaminski, Mark S, Mercer, Jessica, Carty, Shannon, Phillips, Tycel J
Format: Artigo
Sprog:Inglês
Udgivet: Dove 2019
Fag:
Review
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6777435/
https://ncbi.nlm.nih.gov/pubmed/31686856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S155778
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker